Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I - Clinical Trial to Assess Safety of Ultraviolet (UV) Phototherapy for the Prevention of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation

NCT00524953 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00524953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00524953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I - Clinical Trial to Assess Safety of Ultraviolet (UV) Phototherapy for the Prevention of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation
Lead sponsor
Hadassah Medical Organization
Phase
Phase 1
Overall status
Withdrawn
Start date
September 30, 2007
Completion date
September 30, 2013
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allogeneic transplantation (non t-cell depleted)